Study of outcome of high dose oral liposomal vitamin-C in COVID-19 patients
Indian Journal of Basic and Applied Medical Research
; 10(2):95-102, 2021.
Article
in English
| CAB Abstracts | ID: covidwho-1344691
ABSTRACT
Background:
The current pandemic Covid-19 causes several clinical manifestations from asymptomatic presentation to more serious Severe Acute Respiratory Syndrome (SARS) on humans. There is no specific antiviral treatment for Covid-19 and the management is mainly symptomatic.Aim:
To describe the role and outcome of high-dose of oral liposomal vitamin C treatment in a drink form for Covid-19 patients admitted in Government Medical College & ESI Hospital, Coimbatore, India. Materials andmethods:
Patients who admitted to the with the diagnosis of COVID-19 by RTPCR in government medical college and esi hospital Coimbatore during 15 th march 2020 to april 30,2020 are taken for study is one of the earliest cases studies of Covid-19 in the Indian subcontinent.
Full text:
Available
Collection:
Databases of international organizations
Database:
CAB Abstracts
Type of study:
Prognostic study
Language:
English
Journal:
Indian Journal of Basic and Applied Medical Research
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS